Xeomin 100 unit vials
Ended Awarded
- Contract number
- SPE2DB25FE1E5
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $42,643
Award facts
- Contract value 100% obligated
- $42,642.60 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $42,642.60 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Xeomin 100 Unit Vials, with completion targeted for September 9, 2025. This non-set-aside contract represents a direct award under competitive procurement to the pharmaceutical distributor's corporate office, with performance occurring at the company's Conshohocken, Pennsylvania headquarters. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the DLA's supply chain.
This delivery order operates as a child contract under AmerisourceBergen Drug Corp's comprehensive Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which carries a $999,999,999 ceiling value through December 2026. The IDC functions as a global pharmaceutical support vehicle enabling the contractor to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen's extensive federal contract portfolio demonstrates its capability to meet diverse medical procurement requirements across multiple therapeutic domains, positioning it as a primary vendor for specialized pharmaceutical products like Xeomin within the federal healthcare system.
Quick answers
Who was awarded contract SPE2DB25FE1E5?
SPE2DB25FE1E5 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 18, 2025.
How much is contract SPE2DB25FE1E5 worth?
The government has obligated $42,643 on SPE2DB25FE1E5.
Is contract SPE2DB25FE1E5 an order under another contract?
Yes. SPE2DB25FE1E5 is a delivery order under SPE2DB20D1100, an indefinite delivery contract.
Was contract SPE2DB25FE1E5 competed?
The extent of competition for SPE2DB25FE1E5 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award